List of Tables
Table 1. Global Artificial Blood Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Artificial Blood Products Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Artificial Blood Products Market Competitive Situation by Manufacturers in 2024
Table 4. Global Artificial Blood Products Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Artificial Blood Products Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Artificial Blood Products Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Artificial Blood Products Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Artificial Blood Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Artificial Blood Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Artificial Blood Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Artificial Blood Products, Product Type & Application
Table 12. Global Key Manufacturers of Artificial Blood Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Artificial Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Products as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Artificial Blood Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Artificial Blood Products Sales by Region (2020-2025) & (K Units)
Table 18. Global Artificial Blood Products Sales Market Share by Region (2020-2025)
Table 19. Global Artificial Blood Products Sales by Region (2026-2031) & (K Units)
Table 20. Global Artificial Blood Products Sales Market Share by Region (2026-2031)
Table 21. Global Artificial Blood Products Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Artificial Blood Products Revenue Market Share by Region (2020-2025)
Table 23. Global Artificial Blood Products Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Artificial Blood Products Revenue Market Share by Region (2026-2031)
Table 25. North America Artificial Blood Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Artificial Blood Products Sales by Country (2020-2025) & (K Units)
Table 27. North America Artificial Blood Products Sales by Country (2026-2031) & (K Units)
Table 28. North America Artificial Blood Products Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Artificial Blood Products Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Artificial Blood Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Artificial Blood Products Sales by Country (2020-2025) & (K Units)
Table 32. Europe Artificial Blood Products Sales by Country (2026-2031) & (K Units)
Table 33. Europe Artificial Blood Products Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Artificial Blood Products Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Artificial Blood Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Artificial Blood Products Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Artificial Blood Products Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Artificial Blood Products Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Artificial Blood Products Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Artificial Blood Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Artificial Blood Products Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Artificial Blood Products Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Artificial Blood Products Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Artificial Blood Products Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Artificial Blood Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Artificial Blood Products Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Artificial Blood Products Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Artificial Blood Products Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Artificial Blood Products Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Artificial Blood Products Sales (K Units) by Type (2020-2025)
Table 51. Global Artificial Blood Products Sales (K Units) by Type (2026-2031)
Table 52. Global Artificial Blood Products Sales Market Share by Type (2020-2025)
Table 53. Global Artificial Blood Products Sales Market Share by Type (2026-2031)
Table 54. Global Artificial Blood Products Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Artificial Blood Products Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Artificial Blood Products Revenue Market Share by Type (2020-2025)
Table 57. Global Artificial Blood Products Revenue Market Share by Type (2026-2031)
Table 58. Global Artificial Blood Products Price (US$/Unit) by Type (2020-2025)
Table 59. Global Artificial Blood Products Price (US$/Unit) by Type (2026-2031)
Table 60. Global Artificial Blood Products Sales (K Units) by Application (2020-2025)
Table 61. Global Artificial Blood Products Sales (K Units) by Application (2026-2031)
Table 62. Global Artificial Blood Products Sales Market Share by Application (2020-2025)
Table 63. Global Artificial Blood Products Sales Market Share by Application (2026-2031)
Table 64. Global Artificial Blood Products Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Artificial Blood Products Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Artificial Blood Products Revenue Market Share by Application (2020-2025)
Table 67. Global Artificial Blood Products Revenue Market Share by Application (2026-2031)
Table 68. Global Artificial Blood Products Price (US$/Unit) by Application (2020-2025)
Table 69. Global Artificial Blood Products Price (US$/Unit) by Application (2026-2031)
Table 70. Aurum Biosciences Ltd. Company Information
Table 71. Aurum Biosciences Ltd. Description and Business Overview
Table 72. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Aurum Biosciences Ltd. Artificial Blood Products Product
Table 74. Aurum Biosciences Ltd. Recent Developments/Updates
Table 75. HEMARINA SA Company Information
Table 76. HEMARINA SA Description and Business Overview
Table 77. HEMARINA SA Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. HEMARINA SA Artificial Blood Products Product
Table 79. HEMARINA SA Recent Developments/Updates
Table 80. HbO2 Therapeutics Company Information
Table 81. HbO2 Therapeutics Description and Business Overview
Table 82. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. HbO2 Therapeutics Artificial Blood Products Product
Table 84. HbO2 Therapeutics Recent Developments/Updates
Table 85. KaloCyte Inc. Company Information
Table 86. KaloCyte Inc. Description and Business Overview
Table 87. KaloCyte Inc. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. KaloCyte Inc. Artificial Blood Products Product
Table 89. KaloCyte Inc. Recent Developments/Updates
Table 90. SpheriTech Ltd. Company Information
Table 91. SpheriTech Ltd. Description and Business Overview
Table 92. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. SpheriTech Ltd. Artificial Blood Products Product
Table 94. SpheriTech Ltd. Recent Developments/Updates
Table 95. NuvOx Pharma Company Information
Table 96. NuvOx Pharma Description and Business Overview
Table 97. NuvOx Pharma Artificial Blood Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. NuvOx Pharma Artificial Blood Products Product
Table 99. NuvOx Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Artificial Blood Products Distributors List
Table 103. Artificial Blood Products Customers List
Table 104. Artificial Blood Products Market Trends
Table 105. Artificial Blood Products Market Drivers
Table 106. Artificial Blood Products Market Challenges
Table 107. Artificial Blood Products Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Artificial Blood Products
Figure 2. Global Artificial Blood Products Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Blood Products Market Share by Type: 2024 & 2031
Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Product Picture
Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Product Picture
Figure 6. Global Artificial Blood Products Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Artificial Blood Products Market Share by Application: 2024 & 2031
Figure 8. Military
Figure 9. Civil
Figure 10. Global Artificial Blood Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Artificial Blood Products Market Size (2020-2031) & (US$ Million)
Figure 12. Global Artificial Blood Products Sales (2020-2031) & (K Units)
Figure 13. Global Artificial Blood Products Average Price (US$/Unit) & (2020-2031)
Figure 14. Artificial Blood Products Report Years Considered
Figure 15. Artificial Blood Products Sales Share by Manufacturers in 2024
Figure 16. Global Artificial Blood Products Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Artificial Blood Products Players: Market Share by Revenue in Artificial Blood Products in 2024
Figure 18. Artificial Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Artificial Blood Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Artificial Blood Products Sales Market Share by Country (2020-2031)
Figure 21. North America Artificial Blood Products Revenue Market Share by Country (2020-2031)
Figure 22. United States Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Artificial Blood Products Sales Market Share by Country (2020-2031)
Figure 25. Europe Artificial Blood Products Revenue Market Share by Country (2020-2031)
Figure 26. Germany Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Artificial Blood Products Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Artificial Blood Products Revenue Market Share by Region (2020-2031)
Figure 33. China Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Artificial Blood Products Sales Market Share by Country (2020-2031)
Figure 43. Latin America Artificial Blood Products Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Artificial Blood Products Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Artificial Blood Products Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Artificial Blood Products Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Artificial Blood Products by Type (2020-2031)
Figure 53. Global Revenue Market Share of Artificial Blood Products by Type (2020-2031)
Figure 54. Global Artificial Blood Products Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Artificial Blood Products by Application (2020-2031)
Figure 56. Global Revenue Market Share of Artificial Blood Products by Application (2020-2031)
Figure 57. Global Artificial Blood Products Price (US$/Unit) by Application (2020-2031)
Figure 58. Artificial Blood Products Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed